Sharon Osbourne

Ozempic and Zepbound have morphed from diabetes treatment into a cultural phenomenon, helping Novo Nordisk A/S (NYSE:NVO) and Eli Lilly And Co (NYSE:LLY) achieve a combined market cap topping $900 billion. Celebrities flaunt it, Silicon Valley elites swear by it, and analysts predict the GLP-1...

TV personality, Sharon Osbourne, has decided to quit using the popular weight loss drug, Ozempic, after losing more weight than she originally intended, DNyuz reported. The 70-year-old shared her decision during her appearance on Talk TV’s “Piers Morgan Uncensored” alongside her...

Sharon Osbourne shares her adverse experience with the weight loss drug, Ozempic on Bill Maher’s podcast, Parade reports. The 70-year-old celebrity revealed that the first week on Ozempic was challenging due to constant nausea and vomiting. However, these side effects subsided after a couple...